Search

Search results

21 results found

Endogenous Cryptococcal Endophthalmitis in Immunocompetent Host: Case Report and Review of Multimodal Imaging Findings and Treatment

Publication: Journal Article

Amphornphruet, Atchara, Sukhum Silpa-Archa, Janine Preble, and Stephen Foster. 2017. “Endogenous Cryptococcal Endophthalmitis in Immunocompetent Host: Case Report and Review of Multimodal Imaging Findings and Treatment”. Ocul Immunol Inflamm, 1-5.

Validation of the Retinal Detachment after Open Globe Injury (RD-OGI) Score as an Effective Tool for Predicting Retinal Detachment

Publication: Journal Article

Brodowska, Katarzyna, Tomasz Stryjewski, Evangelia Papavasileiou, Yewlin Chee, and Dean Eliott. 2017. “Validation of the Retinal Detachment After Open Globe Injury (RD-OGI) Score As an Effective Tool for Predicting Retinal Detachment”. Ophthalmology 124 (5): 674-78.

Patterns of visual field changes in thyroid eye disease

Publication: Journal Article

Choi, Catherine, Susel Oropesa, Alison Callahan, Lora Glass, Livia Teo, Dean Cestari, Michael Kazim, and Suzanne Freitag. 2017. “Patterns of Visual Field Changes in Thyroid Eye Disease”. Orbit 36 (4): 201-7.

An evidence-based approach to surgical teaching in ophthalmology

Publication: Journal Article

Lorch, Alice, and Carolyn Kloek. 2017. “An Evidence-Based Approach to Surgical Teaching in Ophthalmology”. Surv Ophthalmol 62 (3): 371-77.

INFLIXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE UVEITIS RESISTANT TO CONVENTIONAL IMMUNOMODULATORY THERAPY

Publication: Journal Article

Maleki, Arash, Haitham Sahawneh, Lina Ma, Halea Meese, Yuchen He, and Stephen Foster. 2017. “INFLIXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE UVEITIS RESISTANT TO CONVENTIONAL IMMUNOMODULATORY THERAPY”. Retina 37 (5): 836-43.

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study

Publication: Journal Article

Wallace, David, Raymond Kraker, Sharon Freedman, Eric Crouch, Amy Hutchinson, Amit Bhatt, David Rogers, et al. 2017. “Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study”. JAMA Ophthalmol 135 (6): 654-56.

Antibiotic-resistant microbes date back to 450 MYA, well before the age of dinosaurs

News: May 11, 2017

Survival of mass extinctions helps to explain near indestructible properties of hospital "superbugs" Boston, Mass. — Leading hospital “superbugs,” known as the enterococci, arose from an ancestor that dates back 450 million years — about the time when animals were first crawling onto land (and well...

Xiaoqing Guo, PhD

Person: Instructor in Ophthalmology

Research Area(s): Cornea Mass. Eye and Ear Investigator, Schepens Eye Reserch Institute Profiles: Harvard Catalyst Profile Mass. Eye and Ear Profile (Research)

Bacterial and Fungal Endophthalmitis

Publication: Journal Article

Durand, Marlene. 2017. “Bacterial and Fungal Endophthalmitis”. Clin Microbiol Rev 30 (3): 597-613.

A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease

Publication: Journal Article

Kheirkhah, Ahmad, Antonio Di Zazzo, Vannarut Satitpitakul, Merle Fernandez, Daniel Magilavy, and Reza Dana. 2017. “A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease”. Cornea 36 (7): 799-804.